Storia in 1 fonti

Ovid and Takeda's epilepsy drug gets new life at Perceptive-backed NewCo

Perceptive Advisors is launching a NewCo around soticlestat, Ovid Therapeutics and Takeda's failed epilepsy drug, with up to $294.5 million in milestones owed to Ovid.

Raccontata da

endpoints.news

Timeline cronologica

giovedì 13 agosto 2026·endpoints.news
Ovid and Takeda's epilepsy drug gets new life at Perceptive-backed NewCo
Perceptive Advisors is launching a NewCo around soticlestat, Ovid Therapeutics and Takeda's failed epilepsy drug, with up to $294.5 million in milestones owed to Ovid.